Try our Advanced Search for more refined results
Life Sciences - March, 2024
285 articles
- Petition Watch: Off-Label Ads, Retiree Discrimination & PPE
- Northern Texas Judges Won't Adopt Judge-Shopping Rule
- Hogan Lovells Vet's High Court Debut A Study In Contrasts
- Alleged 'Shadow Trader's Co-Worker Tells Jury Stocks Not Tied
- Judge Denies Injunction For Tyvaso Drug Competitor
- Fed. Circ. Tears Cancer Testing Rivals Apart In Injunction Args
- SEC Wins Extended Asset Freeze Against Biotech Co.
- Allergan Scoffs At Sandoz Bid To Undo $39M Patent Loss
- Judge Axes UpHealth's Claim Estimation Bid In Bankruptcy
- Hedge Fund Beats Vaxart Investor's 'Short-Swing' Profits Suit
- Del. Judge Clears Liquidia To Sell Lung-Disease Drug
- THL's $2.5B Deal To Buy Agiliti Sparks Chancery Suit
- NJ Law Firm Can Keep Benicar Malpractice Suit In Fed. Court
- Exec Says Pharma Co. Yanked Job Offer Over ADHD Medication
- Biotech Co. Inflated Gene Therapy Prospects, Investors Claim
- Stay Interviews Are Key To Retaining Legal Talent
- Penile Implant Doc Awarded $18.3M After Trade Secrets Trial
- Accused 'Shadow Trader' Can't Recall Why He Bought Stock
- Fed. Circ. Won't Stop Sales Of Heart Valve Testers
- 2 Firms Steer Close Of Hildred's $750M Continuation Fund
- Pfizer Wants Moderna Vax IP Case Paused For PTAB Review
- Fees Awarded For 'Feeble' Milk Vitamin Eligibility Argument
- Rite Aid Says It Has Creditor Deal, Gets OK For Plan Vote
- Direct Claims Ruling May Alter Gov't Ties To Software Firms
- MSG-Maker Says Chinese Exporters Skirting Duties Via Malaysia
- Implant Maker's Bribe Case Ripe For Trimming, Judge Says
- Intoxicating Hemp Products: It's High Time For Clarity
- McCarter & English Wins Extra $1.8M In Client Billing Suit
- Merger News Boosts Rivals, 'Shadow Trading' Jury Told
- Latham, Cooley Steer Oncology Firm's $100M IPO
- ITC Judge Recommends Exclusion Order In Tourniquet IP Row
- NY AG, Others Blast Sandoz Deal 'Tax' On Future Settlements
- And Now A Word From The Panel: Benefits Of MDL Transfers
- What Rescheduling Could Mean For Cannabis Bankruptcies
- Eli Lilly Age Bias Suit Over Promotions Nabs Collective Status
- BCBS Can't Escape Therapy Coverage Suit
- Jackson Paints Abortion Clash As Microcosm Of Bigger Brawl
- Banker Describes Confidential Work In 'Shadow Trading' Trial
- Pharmacy Owner Gets 42 Months For $25M Kickback Scam
- FTC Urges Court To Pause Novant's NC Hospital Deal
- Opioid Public Nuisance Claims 'Unique,' Ohio High Court Told
- Pharmacies Need More Protection Against PBM Fee Practices
- Contract Disputes Recap: Facts Differ But Same Rules Apply
- In Abortion Case, Gorsuch Frets 'Rash' Of National Injunctions
- 6 Firms Build $340M SPAC Merger For AI-Driven Medicine Biz
- Pet Drug Maker Faces EU Probe For Axing Pipeline Dog Med
- High Court Wary Of Bid To Limit Abortion Pill Access
- Spray Painting Makes Me A Better Lawyer
- SEC Kicks Off 'Shadow Trading' Case Against Drug Exec
- COVID 'Cure' Claims Can't Sustain Fraud Suit, 9th Circ. Rules
- J&J Exec 'Shocked' Over Atty's Ties With Talc Plaintiffs
- Amgen Sues Colorado After Drug's 'Unaffordable' Rating
- PacBio CEO's Words Haunt Patent Invalidity Arguments
- PTAB Splits On Medtronic Bladder And Bowel Control Patents
- What To Watch As Opioid Litigation Goes To Ohio High Court
- Fed. Circ. Dissent Raises Alarm Over IP Safe Harbor Use
- FTC Intervenes In Teva-Amneal Row To Push Patent Delisting
- Fla. Pharmacy Says It Was Cut From Federal PrEP Program
- Pilot For UK Billionaire Says Stock Tips Case Is Too Vague
- Takeaways From The 2023 DOJ Fraud Section Report
- Paul Weiss-Led AbbVie Inks Up To $212M Deal For Landos Bio
- Judge-Shopping Policy Revisal May Make Issue Worse
- 3rd Circ. Won't Rethink AbbVie Privilege Ruling
- 2nd Circ. Baby Food Ruling Disregards FDA's Expertise
- Catching Up With Delaware's Chancery Court
- Novo Nordisk Inks $1.1B Deal For German Pharma Biz
- Kirkland Guides Ingersoll Rand On $2.3B ILC Dover Buy
- Gilead's Win Upheld In Billion-Dollar HIV Drug Patent Case
- Jury Says Dexcom Infringed 1 Abbott Patent In Mixed Verdict
- Robitussin Buyers' Lack Of Receipts Dooms Labeling Cert.
- Expert's Sanctions Off Limits In SEC's 'Shadow Trading' Trial
- Pharma Co. Brass Overhyped ALS Drug Efficacy, Suit Says
- Up Next At High Court: Abortion, Jury Trials And Estate Tax
- Md. University Says Psilocybin Trade Theft Suit Belongs In US
- $900M Trade Secrets Case Against Kaiser Foundation Flops
- Final OK Sought For Economic Loss Deal In CPAP Recall MDL
- Radiology Co., Trustee Must Face Ex-Worker's ESOP Suit
- Vanda's Obviousness Appeal Isn't Worthwhile, Teva Tells Justices
- High Court Mifepristone Battle Goes Beyond Abortion
- Ex-Drug Rep Won't Serve More Time After 1st Circ. Victory
- NJ Appeals Court Shuts Down Fired White Worker's Bias Suit
- US Greenlights Novartis' $2.9B MorphoSys Takeover
- UK Litigation Roundup: Here's What You Missed In London
- 87-Year-Old Billionaire Lewis Seeks No Jail For Insider Trading
- Del. Courts Examining 'Colonoscopy'-Like Bylaw Rules
- LifeCell Cleared Of Liability In NJ Strattice Hernia Mesh Trial
- SEC's 'Shadow Trading' Trial To Test Insider Info Boundaries
- Colo. Distributor Seeks $2.3M Sanction For Stryker Spoilation
- Schumer Urges Texas District To Adopt Judge-Shopping Rule
- Ill. Judge Leaves Outcome Health Execs' Convictions Intact
- MDL Claims Over Merck's Gardasil Vax Get Trimmed
- 6th Circ. Revives McKee's Network Plan Fight With Thrifty Med
- Calif. Panel Revives Diner's COVID Sanitization Coverage Bid
- Tribe's Opioid Suit Can Head To State Court, Okla. Judge Says
- CymaBay Investor Sues For Books On $4.3B Gilead Merger
- Avoid Major Extension Of Merger Reach, EU High Court Urged
- Business Coalition Rebuffs Biden Plan To Seize Drug Patents
- Home Health Cos. Stiffed Workers On OT Pay, Suit Claims
- Assessing FDA Pathways For Genome-Edited Plant Foods
- Teleflex Catheter Patent Makes It Through Fed. Circ.
- Woman Lost Independence Due To Strattice Mesh, Jurors Told
- 3rd Circ. Agrees Investors Have No Case Against Vax Maker
- Proposed MDL Management Rule Needs Refining
- 6th Circ. Doubtful Of Hospital Workers' Vax Exemption Claim
- Why Oncology Deal Making Continues To Fuel Biotech M&A
- Fed. Circ. Upholds Edwards' PTAB Win On Heart Valve Patent
- 6th Circ. Zeroes In On CBA In Vax Bias Preemption Battle
- Chancery Denies Icahn Midcase Appeal In Illumina Board Suit
- Greenberg Traurig Adds Jackson Walker FDA Pro In Houston
- Judicial Independence Is Imperative This Election Year
- 4th Circ. Backs Rockefeller Group in Guatemalans' Syphilis Suit
- Endo Plan To Trim $5B In Debt Confirmed By NY Judge
- NIST March-In Framework Is As Problematic As 2021 Proposal
- PTAB To Analyze Moderna COVID Vaccine Patents
- Jenner & Block-Led Lonza To Buy Roche's $1.2B US Facility
- Digital Comms Filings Bolster Record EPO Applications
- Document Retention Best Practices To Lower Litigation Risks
- Int'l Olympic Committee Rips Russia For Politicizing Sports
- Top Attorney For Bristol-Myers Squibb Earned $5.9M In '23
- Riding My Peloton Bike Makes Me A Better Lawyer
- Boehringer Wins Diabetes Treatment Patent On Appeal In EU
- How The Supreme Court Could Narrow Chevron
- 2 Biotechs Unveil Separate Fundings Totaling $325M
- Law360 Announces The Members Of Its 2024 Editorial Boards
- US Chamber's Litigation Funding Concerns Spur 2 State Laws
- Healthcare Policy Roundup: HHS Budget, Telehealth, PBMs
- Schumer Scolds McConnell For Judge-Shopping Policy Rebuff
- Acorda Says Tribunal Ignored Patent Law In MS Drug Feud
- Law Firm Hit With Suit Over Abandoned Patent Application
- Ala. Frozen Embryo Ruling Creates Risks for Managed Care Orgs
- NBA Fraudster Dodges Prison After Cooperation, Testimony
- Skin Care Drug Co. Can Ask Creditors To OK Ch. 11 Plan
- Cancer Patient Fights Monsanto's Philadelphia Roundup Win
- Future Of Judge-Shopping Reform Hazy After Rule Proposal
- OptumRx Can't Get Motley Rice Disqualified From Opioid MDL
- IFF Selling Pharma Unit To French Co. Roquette In $2.85B Deal
- Spartan Arbitration Tactics Against Well-Funded Opponents
- Patent Suit Over AstraZeneca's Tagrisso Heads To Jury
- 2nd Circ. Rejects 'New Standard' Of Patent Monopolies
- 4th Circ. Sends Opioid 'Nuisance' Question To W.Va. Top Court
- Conn. Pharmacy, FDA Say They've Settled Suit Over Probe
- Biotech Ardelyx Beats Shareholder Suit Over Kidney Drug
- High Court Doubts Feds Coerced Social Media Cos.
- Kimberly-Clark Gets OK For $6M Deal Over Tainted Wipes
- Leerink Enticed Goldman Exec With False Promises, Suit Says
- Uncertainty Surrounds Patent Eligibility Restoration Bill
- Amyris Gets OK To Settle Pot Co.'s $15M Trade Secret Suit
- Catching Up With Delaware's Chancery Court
- Pfizer To Reduce Stake In Haleon To 24% Through Share Sale
- Up Next At High Court: Gov't Jawboning & Retaliatory Arrests
- Judiciary Clarifies Judge Shopping Policy After Senator Letter
- 8th Circ. Nixes Arbitration Bid In $9M Chinese PPE Fight
- 'Cobra Venom' Painkiller Co. Inks Deal To Settle SEC Claims
- CSA Case Could Shift Intrastate Commercial Cannabis
- Enfamil Maker Hit With $60M Jury Verdict In Infant Death Suit
- Hospitals Say Constitutional Defenses Valid In FTC Merger Row
- How AI May Be Used In Fintech Fraud — And Fraud Detection
- Ex-Fugitive Behind Fake Silver COVID Cure Pleads Guilty
- Conservative Law Group Asks Justices To Hear FDA Vape Suit
- What Recent Study Shows About AI's Promise For Legal Tasks
- Pharma Co. Misled Investors On Research Methods, Suit Says
- Deals Rumor Mill: Trump-Musk, Icahn-Illumina, Paramount
- Feds Seek 20 Mos. For Aegerion Fraud 'Puppet Master'
- Drug Wholesalers Want Preliminary OK On $265M Sandoz Deal
- Trial Challenging NC Abortion Restrictions Pushed To July
- EPA Slashes Ethylene Oxide Emissions Levels For Sterilizers
- 9th Circ. Unsure If Abortion Pill Suit Harms Red States
- Pharma Co. CEO Partly Beats Investor Suit Over Kidney Drug
- HHS To Investigate Whether Cyberattack Exposed Patient Data
- Planned Parenthood Foe Calls Immunity Claim 'Half-Baked'
- Aetna Can't Avoid Bias Suit Over Fertility Treatment Policy
- Jury Must Weigh Willfulness In Secrets Case, Calif. Court Says
- BigLaw Paper Poacher Gets 15 Mos. In Merck Insider Case
- Fed. Circ. Patent Lesson: No Contradiction, No Indefiniteness
- Eli Lilly GC's Pay Jumped To $7M In 2023 Amid Stock Boom
- Daiichi Urges Court To OK Arbitrator's Award Against Seagan
- Federal Circuit Won't Reconsider Axing Tyvaso Patent
- Judiciary Touts New Policy To Rein In Judge Shopping
- NY Jury Rules Some Claims About Prevagen Are Misleading
- 2nd Circ. Revives Parts Of McKesson Whistleblower Suit
- Breast Implant Co.'s $90M DIP OK'd With Creditor Protections
- Ex-Biopharma CEO Sues For Post-Sale Share Appraisal In Del.
- Sorrento Ch. 11 Will Stay In Texas
- Reps Push Regulators For Answers On Marijuana Research
- 11th Circ. FMLA Ruling Deepens Divide Over Causation
- Decline In Same-Industry M&A Tells A Nuanced Policy Story
- Nurses' Challenge To NJ Vaccine Mandate Moot, Judge Rules
- Pharmacy Calls $11M False Claims Case A 'House Of Cards'
- Paul Weiss' Digital Tech Chair On AI's Promises And Perils
- Insider Trader Cites 'Carelessness' Of BigLaw Ex-Girlfriend
- Acadia Investors Get Class Cert. In Suit Over Parkinson's Drug
- Illumina Brass Faces Shareholder Suit Over Grail Deal Debacle
- 3rd Circ. Finds No Reason To Disturb AbbVie Privilege Ruling
- Judge OKs Eye Care Tech Co.'s $8M DIP Request
- Fed. Circ. OKs Boston Drug Developer's Patent Win
- Pfizer Slams Ex-Compliance Officer's Whistleblower Claims
- What's At Play In Rising Lanham Act Cases At The ITC
- Walmart Fails To Sink Feds' Opioid Crisis Lawsuit
- BIPA's Statutory Exemptions Post-Healthcare Ruling
- SEC Can't Rely On 'Flawed' Ruling To Avoid Retrial, Atty Says
- Key Factors In Establishing Compelling Merits At The PTAB
- Pfizer Defeats French Group's Bid For Vax Docs At 2nd Circ.
- Catching Up With Delaware's Chancery Court
- Trump 'An Existential Threat' To Rule Of Law, Attys Warn
- Inside The Climactic Clash Over Skyrocketing MDL Caseloads
- Cahill Has 'Great Ambitions' To Take IP Litigation By Storm
- FDA Pumps Brakes On Eli Lilly Alzheimer's Drug Approval
- UK Enforcers To Appeal Nixed £100M Hydrocortisone Fine
- Colo. DNA Scientist Fudged Data For 650 Cases, Police Say
- 7th Circ. Wants 'Roadmap' For Ill. Workplace Disease Law
- Sorrento Gets OK For $2M Ch. 11 Funding Infusion, Asset Sale
- Business Litigators Have A Source Of Untapped Fulfillment
- Abortion, Drug Costs Top Health Issues in State Of The Union
- Petition Watch: Student Athletes, Oil Spills & Preemption
- Judges Say Facing Threats And Vitriol Now Part Of The Job
- Judge Doubts Medicare Drug Pricing Amounts To 'Taking'
- IP Forecast: 2nd Circ. To Consider Whether Seltzer Is Beer
- Harpoon Shareholder Sues For Records On $680M Merck Buy
- Sens. Tell Stores To Get Illegal E-Cigs Off Their Shelves
- What FTC's 'Killer Acquisition' Theory Means For Pharma Cos.
- Fed. Circ. Says IP License May Be Part Of Procurement Deal
- Feds Want 3 Years For Trader Who Spied BigLaw Ex's Binder
- Moses & Singer Healthcare Atty Joins Day Pitney In Hartford
- Skiing Makes Me A Better Lawyer
- Activist Caligan Sets Sights On Anika Therapeutics Again
- Top Calif. Antitrust Atty Says Criminal Cases On The Horizon
- Garland On AI Crime, And A Taylor Swift Tune For DOJ
- Juul MDL Judge Asks Feds To Probe AI Fraud In $45.5M Deal
- Pa. Pharma Co. Cops To Adulterated-Drug Charges
- CBP Details Apple Watch Redesign OK In Masimo Patent Row
- J&J Seeks Exit From Suit Over Stelara Exclusivity
- 5th Circ. Weighs 'Very Complex' Chemo Hair Loss Dispute
- PTAB Has To Rehear Challenge In Biotech Row
- The Road Ahead For Florida's Drug Importation Program
- Corporate Vet Joins Orrick's Tech Group From Wilson Sonsini
- Assessing CDC's Revised Guideline On Opioid Prescriptions
- Biopharmaceutical Biz Closes $259M Upsized Funding Round
- Challenge To Pfizer Diversity Program Fails At 2nd Circ.
- Ex-Stimwave CEO Found Guilty Of Healthcare Fraud
- Ohio Neurologist Can't Shorten His Drug Kickback Sentence
- UMass, L'Oreal Fight Over Anti-Aging Cream May Be Near End
- White House To Crack Down On Illegal, Unfair Pricing
- Fed. Circ. Upholds Axing Pfizer Vax IP But Calls For More Info
- Gibson Dunn AI Leader On Weathering The AI Policy Blizzard
- Pharmacist Takes Deal In Mich. Over Fatal Meningitis Outbreak
- Magnolia Medical Again Sues Kurin Over Sepsis IP
- CVS Again Defeats NY AG's Drug Rebate Tying Claims
- FTC Chair Decries PE's Healthcare Impacts As Probe Starts
- Avadel Told To Pay Jazz Pharma $234K Over Narcolepsy Drug IP
- Think Like A Lawyer: Forget Everything You Know About IRAC
- GOP Sens. Voice Concern Over Biden Plan To Claim Patents
- FDA Rejection Of Fosamax's Label Fix Not Final, 3rd Circ. Told
- IP Litigation Vet Joins Wiggin and Dana's NY Office From LTL
- DLA Piper Adds Merck SVP As New Life Sciences Sector Chair
- Valeant Ruling May Pave Way For Patent-Based FCA Suits
- Monsanto Nabs 1st Win In Philly's Roundup Trial Blitz
- J&J Trial Over Doctor's Cancer Death Ends In Hung Jury
- Crowell & Moring Int'l Names Global Life Sciences Head
- Elanco Urges Justices To Preserve Junk Fax Win
- WTO Conference Ends Without COVID IP Waiver Expansion
- Trial Of Ex-Stimwave CEO Over Medical Device Nears End
- Bayer Pays $310M For European Rights To Heart Drug
- French Spinal Care Co. Can't Get €4.2M Award Enforced
- Sorrento Creditors Fight To Keep Ch. 11 In Texas
- Antibe Therapeutics To Pay Nuance $24M In Licensing Fight
- Catching Up With Delaware's Chancery Court
- Gov't Says AI Patent Gap Between US And China Is Growing
- Ventyx Investor Says Co. Overhyped Psoriasis Drug
- Adamas' Ex-COO Agrees To $4.6M Deal In Investor Suit
- 3rd Circ. Preview: Exxon Whistleblower Case Fuels March
- USPTO Wants To Make Patent Amendment Pilot Official
- Blockbuster Drug Sales Help Keep J&J Patent Alive
- J&J's Talc Lit The Spark For Doctor's Fatal Cancer, Jury Told
- Cannabis Consulting Co. Says Clinic Owes $101K On Contract
- NY Judge Tosses $6.4B BMS Investor Action For Good
- 55K Labcorp 401(k) Participants Seek Class Cert. In NC
- Tort Report: $42M Med Mal Award; Hot Coffee Suit In The Air
- CVS, Walgreens Receive FDA's OK To Dispense Abortion Drug
- Suits Against Insulin Pricing Are Driven By Rebate Addiction
- Gilead, Cipla Ink Deal To End HIV Drug Buyers' Antitrust Suit
- Panel Backs Tossing Of Eli Lilly, Bayer Drug Marketing Suits
- Lessons For D&O Policyholders From Pharma Co. Ruling
- Morgan Lewis Adds Otsuka Pharmaceutical Atty In DC
- How Firms Can Ensure Associate Gender Parity Lasts
- UK Litigation Roundup: Here's What You Missed In London